An update on the management of Chagas cardiomyopathy

Authors: Rocha, Manoel OC; Teixeira, Mauro M; Ribeiro, Antonio L

Source: Expert Review of Anti-Infective Therapy, Volume 5, Number 4, August 2007 , pp. 727-743(17)

Buy & download fulltext article:

Price: $73.00 plus tax (Refund Policy)

Abstract:

Chagas disease, caused by the protozoan parasite Trypanosoma cruzi, infects nearly 18 million people in Latin America and mainly affects the heart, causing heart failure, arrhythmias, heart block, thromboembolism, stroke and death. In this review, the clinical diagnosis and management of Chagas cardiomyopathy are discussed. Particular emphasis is placed on the clinical staging of patients and the use of various diagnostic tests that may be useful in individualizing treatment of the two most relevant clinical syndromes, that is, heart failure and arrhythmias. The relevance of specific treatments are discussed, stressing the important role of parasite persistence in disease pathogenesis. We also discuss new therapy modalities that may have a role in the treatment of Chagas cardiomyopathy.

Keywords: arrhythmia; benznidazole; carvedilol; Chagas disease; heart block; heart failure

Document Type: Research article

DOI: http://dx.doi.org/10.1586/14787210.5.4.727

Publication date: 2007-08-01

More about this publication?

Expert Review of Anti-infective Therapy provides expert reviews on therapeutics and diagnostics in the treatment of infectious disease. Coverage includes antibiotics, drug resistance, drug therapy, infectious disease medicine, antibacterial, antimicrobial, antifungal and antiviral approaches, and diagnostic tests.
Editorial Board
Information for Authors
Submit a Paper
Subscribe to this Title
Information for Advertisers
Terms & Conditions
Information for Librarians
Free Trials
ingentaconnect is not responsible for the content or availability of external websites